Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print August 6, 2008, doi:10.1212/01.wnl.0000319691.50117.54)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz
Right arrow CME: Take the course for this article:
Volume 71, Number 11, September 9, 2008
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000319691.50117.54v1
71/11/804    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Young, V. G.
Right arrow Articles by Kril, J. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, V. G.
Right arrow Articles by Kril, J. J.
Related Collections
Right arrow MRI
Right arrow All Cerebrovascular disease/Stroke
Right arrow All Cognitive Disorders/Dementia
NEUROLOGY 2008;71:804-811
© 2008 American Academy of Neurology

Neuropathologic correlates of white matter hyperintensities

Vanessa G. Young, PhD, Glenda M. Halliday, PhD and Jillian J. Kril, PhD

From the Disciplines of Medicine (V.G.Y., J.J.K.) and Pathology (J.J.K.), The University of Sydney; and Prince of Wales Medical Research Institute and the University of New South Wales (G.M.H.), Sydney NSW, Australia.

Address correspondence and reprint requests to Dr. Jillian J. Kril, Department of Pathology, University of Sydney, Sydney, 2006, Australia jilliank{at}med.usyd.edu.au

Objective: White matter hyperintensities (WMH) are commonly seen on neuroimaging scans, but their underlying histopathologic substrate is unclear. The aim of this work was to establish the pathologic correlates of WMH in unselected elderly cases using two study designs. To avoid potential bias from comparisons of different anatomic regions, study 1 compared, region-by-region, the severity of WMH determined in vivo with measures of each of the major white matter (WM) components. Study 2 compared the histopathology of WMH with normal WM.

Methods: Study 1: The periventricular and deep WM regions of three lobes in 23 brains with in vivo MRI scans were investigated using histologic and immunohistochemical stains. The severity of each pathologic measure was correlated with WMH severity determined using the Scheltens scale. Study 2: Lesioned and nonlesioned areas identified by postmortem MRI in the frontal WM of 20 brains were examined histologically and immunohistochemically.

Results: No single pathologic variable correlated with the severity of WMH; however, a multiple stepwise regression analysis revealed that vascular integrity predicted total Scheltens score (β = –0.53, p = 0.01). Comparison of lesioned and nonlesioned areas demonstrated that vascular integrity was reduced in WMH [t(18) = 3.79, p = 0.001]. Blood–brain barrier integrity was also found to be reduced in WMH [t(5) = –5.31, p = 0.003].

Conclusions: White matter hyperintensities (WMH) involve a loss of vascular integrity, confirming the vascular origin of these lesions. This damage to the vasculature may in turn impair blood–brain barrier integrity and be one mechanism by which WMH evolve.

Abbreviations: AD = Alzheimer disease; APP = amyloid precursor protein; dMBP = degraded myelin basic protein; FLAIR = fluid-attenuated inversion recovery; GFAP = glial fibrillary acidic protein; hGLUT-5 = human glucose transporter-5; HLA-DR = human leukocyte antigen-DR domain; PM = postmortem; WM = white matter; WMH = white matter hyperintensities.


Supplemental data at www.neurology.org

e-Pub ahead of print on August 6, 2008, at www.neurology.org.

Supported by a grant from the Australian Brain Foundation and used material from the Australian Brain Donor Programs, which receives support from the National Health and Medical Research Council of Australia. V.Y. is the recipient of an Australian Postgraduate Research Award scholarship. The authors are grateful for the assistance of Patricia Waley and the staff of the Prince of Wales Medical Research Centre Tissue Resource Centre.

Disclosure: The authors report no disclosures.

Received September 25, 2007. Accepted in final form May 1, 2008.




This article has been cited by other articles:


Home page
JWatch NeurologyHome page
Pathology of White-Matter Hyperintensities
Journal Watch Neurology, December 16, 2008; 2008(1216): 3 - 3.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.